Clinical Trials Browser

Hematologic Diseases, Leukemia, Neoplasms, Leukemia, Promyelocytic, Acute, Hematologic Neoplasms

NCT07296445 2025-12-29

LATITUDE

Phase 3 Not yet recruiting

120 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT02712905 2025-11-04

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Phase 1/2 Terminated

116 enrolled 36 charts

MyeloidOther hematologic neoplasmThoracic

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Primary Myelofibrosis, Small Cell Lung Carcinoma

NCT04303169 2025-10-27

KEYMAKER-U02

Phase 1/2 Completed

146 enrolled

Dermatologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT04305041 2025-08-29

KEYMAKER-U02

Phase 1/2 Completed

100 enrolled

Dermatologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT04282668 2024-12-09

A Study of TAS1440 With ATRA in Subjects With r/r AML

Phase 1 Terminated

52 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02842827 2023-07-11

IMG-7289-CTP-101

Phase 1/2 Completed

45 enrolled 41 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00962767 2009-08-20

Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission

Phase 3 Completed

168 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

QUATRO-APL

LATITUDE

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

KEYMAKER-U02

KEYMAKER-U02

A Study of TAS1440 With ATRA in Subjects With r/r AML

IMG-7289-CTP-101

Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission